As of June 2026, GEHC's current EPS stands at $4.18, according to the latest financial reports. For the year 2025, the company recorded an earnings per share (EPS) of $4.56, which marks an increase compared to its EPS of $4.37 in 2024. GEHC reported an EPS of $0.85 for the quarterly report ending on Mar 31, 2026.
For 2025, GE HealthCare Technologies's EPS was $4.56, an increase of 4.3% from $4.37 in 2024. For the fiscal quarter that ended on Mar 31, 2026, the per-share earnings was $0.85, showing a 30.9% decrease from the same quarter last year. For the twelve months ending March 2026, the EPS is $4.18. For the year 2024, the yearly earnings per share was $4.37, marking an increase of 43.3% from 2023.
GE HealthCare Technologies has registered a decrease in EPS of 30.9% during the last 12 months (YoY, quarterly). In the last three years, GEHC recorded an average annual EPS growth rate of 2.6%.
| Stock name | Price to Earnings | EPS grwoth 1Y | EPS grwoth 3Y | EPS grwoth 5Y |
|---|---|---|---|---|
| GEHC GE HealthCare Technologies Inc | 15.59 | 4.3% | 2.6% | N/A |
| OBIO Orchestra BioMed Holdings Inc | N/A | 33.1% | N/A | N/A |
| OM Outset Medical Inc | N/A | 85.5% | N/A | N/A |
All data is based on quarterly TTM periods, unless otherwise specified.